 Baird Financial Group Inc. raised its stake in Heron Therapeutics Inc NASDAQ:HRTX by 22.8 during the first quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The fund owned 11,517 shares of the biotechnology companys stock after purchasing an additional 2,140 shares during the quarter. Baird Financial ... 